Dr. Joshua Rosenblatt, MD

Dr. Rosenblatt practices at NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital.

Dr. Rosenblatt's NPI, 1669826152, was assigned on April 20, 2016. Dr. Rosenblatt graduated from Tufts University School Of Medicine in 2016. Dr. Rosenblatt holds New York license 307592.

Dr. Rosenblatt's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center, at 525 East 68th Street, New York, NY 10065 in New York County. The practice phone is (212) 746-5454.

Dr. Rosenblatt's primary practice is NewYork-Presbyterian/Weill Cornell Medical Center in New York, New York, part of NewYork-Presbyterian Hospital. The medical group on file is Weill Cornell Physicians. Dmand AI also links Dr. Rosenblatt to 2 more clinical labs and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Rosenblatt practices, 4 sites in all. Vendor and product names are available with a free account.

Infectious disease is Dr. Rosenblatt's primary specialty in the NPI Registry, under taxonomy code 207RI0200X. Dr. Rosenblatt is board certified in infectious disease by the American Board of Internal Medicine. Dmand AI has Dr. Rosenblatt's licenses on file in 2 states: New York and Pennsylvania.

Dmand AI lists acute skin infection, hiv/aids and joint or bone infection among the conditions Dr. Rosenblatt treats.

CMS data shows 325 Medicare services from Dr. Rosenblatt across 5 procedure codes in 2024, for 129 Medicare patients. Medicare paid $28,785 for them.

CMS counts 129 Medicare patients who saw Dr. Rosenblatt in 2024. The largest group is 65 to 74, with 46 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 46% are also on Medicaid. Their average risk score is 3.68, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Rosenblatt's median patient age at 58, with 45% women.

In 2024, Dr. Rosenblatt wrote 103 Medicare Part D claims for 31 patients. 90% of them were for generic drugs. CMS names the drug for 25 of them, across 2 drugs with 11 or more claims each, at $382 in total drug cost. In 2023, CMS named 27 claims across 2 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Rosenblatt for performance year 2024, reported through an alternative payment model (APM). Dr. Rosenblatt accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Rosenblatt as offering telehealth.

Dmand AI links 4 papers to Dr. Rosenblatt, published from 2011 to 2022. Dr. Rosenblatt's most frequent co-authors are Stanley Evan Cooper, MD, Roy M. Gulick, MD, MPH and Alberto E. Paniz-Mondolfi, MD.

CMS Open Payments shows 2 general payments to Dr. Rosenblatt from 1 drug or device company from 2024 to 2025. Food and beverage make up the largest share, 100% of the total. Merck Sharp & Dohme Corporation paid the most, $132.

Dmand AI lists 3 awards for Dr. Rosenblatt, most recently Rising Star in 2025.

Dr. Rosenblatt graduated from Tufts University School Of Medicine in 2016. Dr. Rosenblatt is a member of ACP, AMA and IDSA.

Dr. Rosenblatt is in network with 16 carriers, including Aetna, United Healthcare and Blue Cross Blue Shield of Michigan. PPO plans come from the most carriers, 11. Check the plan with the practice before a visit.